NeuraPex AI has developed an innovative assistive platform that delivers early, AI-powered insights for neurology and dermatology conditions. The tool analyzes patient symptoms, images, and clinical data to provide rapid preliminary assessments, risk scoring, and specialist referral recommendations aiming to accelerate diagnosis and improve outcomes in resource-limited settings.
Glimpse:
The platform combines computer vision for skin lesion analysis and neurological symptom pattern recognition with natural language processing to interpret patient histories. It offers real-time triage support, differential diagnosis suggestions, and visual explanations for clinicians and patients. Designed for use in primary care, telehealth, and outpatient clinics, NeuraPex assists in early detection of conditions like stroke, Parkinson’s, melanoma, psoriasis, and eczema reducing diagnostic delays and unnecessary referrals.
NeuraPex AI, an emerging healthtech startup, has launched a specialized assistive platform that targets two high-burden specialty areas: neurology and dermatology. The solution is built to support frontline doctors, especially in tier-2/3 cities and rural clinics, by providing fast, reliable preliminary insights that help guide next steps without replacing specialist judgment.
Core capabilities of the NeuraPex platform include:
Neurology module symptom-based risk scoring for stroke, epilepsy, Parkinson’s, dementia, and neuropathy; facial analysis for movement disorders; integration with wearables for tremor/gait monitoring Dermatology module image analysis for skin lesions, rashes, pigmentation changes, and wounds; melanoma risk stratification; progression tracking over time Multimodal input accepts text descriptions, voice notes, photos, and basic vitals to generate structured reports Explainable outputs visual heatmaps, probability breakdowns, and guideline references so clinicians understand and trust the suggestions Referral & triage engine recommends urgency level (immediate ER, specialist consult, watchful waiting) with clear rationale
The platform is trained on diverse Indian datasets to handle local variations in skin tones, disease presentation, and language use. It supports offline inference on edge devices for low-connectivity areas and complies with DPDP Act privacy requirements, ABDM interoperability standards, and CDSCO guidelines for software as medical device.
Early pilots in select hospitals and primary care centres have shown reductions in diagnostic uncertainty, faster specialist referrals for high-risk cases, and improved patient satisfaction due to quicker explanations and visual aids. NeuraPex plans phased rollout starting with urban OPDs before expanding to rural telehealth networks.
This launch reflects the growing maturity of India-first AI tools that focus on practical, specialty-specific support rather than general-purpose chatbots directly addressing overburdened specialists and delayed diagnoses in neurology and dermatology.
“Early insight changes everything in neurology and dermatology. Our platform gives doctors the confidence to act sooner without replacing their expertise.”
By
HB Team
